0 items USD 0.00Search
Your search for "gbi research re evaluating pharmaceutical pipelines emerging markets biologics orphan drugs" gave back 34262 results.
Indian pharma retail market is expected to grow in near future as aging and growing population, rising income levels, and emerging medical conditions...
Catalog:
NAVADHI
June 2019
Price: USD 1,000.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. From being an enzyme venture, Biocon successfully emerged as a...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
India pharmaceutical market was the 11 th largest pharmaceuticals market by value in the world in 2017. It is expected to register second highest...
Catalog:
NAVADHI
April 2019
Price: USD 3,500.00
With much-awaited approval of biosimilar interchangeability by FDA, the dynamics in the much nascent US biosimilars market is about to change with...
Catalog:
Rockville Research
January 2017
Price: USD 1,200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. Chemical, Industrial & Pharmaceutical Laboratories, now known as...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. Dr. Reddy’s Laboratories is an India based multinational...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. Torrent Pharmaceuticals Limited is the 8th largest pharmaceutical...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. The key business segments of Aurobindo Pharma are APIs, Formulations...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. Sun Pharmaceuticals is a multinational company and was established by...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. The business segments of Lupin mainly comprise of APIs and...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. Ipca Labs was founded by K.B. Mehla and Dr. N.S. Tibrawala in 1949...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. Abbott India Limited is a public listed company and a subsidiary of...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
India pharmaceuticals market is expected to be worth USD 33.18 billion by 2023. The business segments of Divis labs are Active Pharma Ingredients,...
Catalog:
NAVADHI
June 2019
Price: USD 200.00
In recent years, multinational pharmaceutical companies have focused on core business by selling API and preparation factories. We estmiate that with...
Catalog:
AEI
May 2021
Price: USD 3,000.00
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Orphan Drugs market will undergo major changes. According...
Catalog:
Arsta
May 2023
Price: USD 3,600.00
